- Previous close
18.73 - Open
18.01 - Bid 17.92 x 800
- Ask 17.95 x 1100
- Day's range
17.53 - 18.23 - 52-week range
5.65 - 25.74 - Volume
11,324,279 - Avg. Volume
9,535,084 - Market cap (intra-day)
3.864B - Beta (5Y monthly) 1.06
- PE ratio (TTM)
223.13 - EPS (TTM)
0.08 - Earnings date 4 Nov 2024 - 8 Nov 2024
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
21.93
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
www.forhims.com1,046
Full-time employees
31 December
Fiscal year ends
Consumer Defensive
Sector
Household & Personal Products
Industry
Recent news: HIMS
View more
Related videos: HIMS
Performance overview: HIMS
Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: HIMS
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: HIMS
View moreValuation measures
Market cap
4.05B
Enterprise value
3.84B
Trailing P/E
234.12
Forward P/E
44.64
PEG ratio (5-yr expected)
--
Price/sales (ttm)
3.89
Price/book (mrq)
11.20
Enterprise value/revenue
3.60
Enterprise value/EBITDA
162.33
Financial highlights
Profitability and income statement
Profit margin
1.70%
Return on assets (ttm)
2.17%
Return on equity (ttm)
5.31%
Revenue (ttm)
1.07B
Net income avi to common (ttm)
18.1M
Diluted EPS (ttm)
0.08
Balance sheet and cash flow
Total cash (mrq)
227.29M
Total debt/equity (mrq)
3.17%
Levered free cash flow (ttm)
82.37M